
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Gregory Poore, Evguenia Kopylova, Qiyun Zhu, et al.
Nature (2020) Vol. 579, Iss. 7800, pp. 567-574
Open Access | Times Cited: 860
Gregory Poore, Evguenia Kopylova, Qiyun Zhu, et al.
Nature (2020) Vol. 579, Iss. 7800, pp. 567-574
Open Access | Times Cited: 860
Showing 1-25 of 860 citing articles:
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Deborah Nejman, Ilana Livyatan, Garold Fuks, et al.
Science (2020) Vol. 368, Iss. 6494, pp. 973-980
Open Access | Times Cited: 1626
Deborah Nejman, Ilana Livyatan, Garold Fuks, et al.
Science (2020) Vol. 368, Iss. 6494, pp. 973-980
Open Access | Times Cited: 1626
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Golnaz Morad, Beth A. Helmink, Padmanee Sharma, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5309-5337
Open Access | Times Cited: 1083
Golnaz Morad, Beth A. Helmink, Padmanee Sharma, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5309-5337
Open Access | Times Cited: 1083
The microbiome and human cancer
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 887
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 887
A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis
Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2025-2025
Open Access | Times Cited: 620
Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2025-2025
Open Access | Times Cited: 620
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Jorge Luis Galeano Niño, Hanrui Wu, Kaitlyn D. LaCourse, et al.
Nature (2022) Vol. 611, Iss. 7937, pp. 810-817
Open Access | Times Cited: 455
Jorge Luis Galeano Niño, Hanrui Wu, Kaitlyn D. LaCourse, et al.
Nature (2022) Vol. 611, Iss. 7937, pp. 810-817
Open Access | Times Cited: 455
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Y. M. Dennis Lo, Diana Han, Peiyong Jiang, et al.
Science (2021) Vol. 372, Iss. 6538
Closed Access | Times Cited: 447
Y. M. Dennis Lo, Diana Han, Peiyong Jiang, et al.
Science (2021) Vol. 372, Iss. 6538
Closed Access | Times Cited: 447
Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 370
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 370
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 329
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 329
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Lian Narunsky-Haziza, Gregory D. Sepich‐Poore, Ilana Livyatan, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3789-3806.e17
Open Access | Times Cited: 319
Lian Narunsky-Haziza, Gregory D. Sepich‐Poore, Ilana Livyatan, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3789-3806.e17
Open Access | Times Cited: 319
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 319
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 319
Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans
Connie Ha, Anthony Martin, Gregory D. Sepich‐Poore, et al.
Cell (2020) Vol. 183, Iss. 3, pp. 666-683.e17
Open Access | Times Cited: 311
Connie Ha, Anthony Martin, Gregory D. Sepich‐Poore, et al.
Cell (2020) Vol. 183, Iss. 3, pp. 666-683.e17
Open Access | Times Cited: 311
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Herbert Tilg, Timon E. Adolph, Michael Dudek, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1596-1607
Closed Access | Times Cited: 303
Herbert Tilg, Timon E. Adolph, Michael Dudek, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1596-1607
Closed Access | Times Cited: 303
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
Herbert Tilg, Timon E. Adolph, Alexander R. Moschen
Hepatology (2020) Vol. 73, Iss. 2, pp. 833-842
Open Access | Times Cited: 295
Herbert Tilg, Timon E. Adolph, Alexander R. Moschen
Hepatology (2020) Vol. 73, Iss. 2, pp. 833-842
Open Access | Times Cited: 295
The dynamic lung microbiome in health and disease
Jake G. Natalini, Shivani Singh, Leopoldo N. Segal
Nature Reviews Microbiology (2022) Vol. 21, Iss. 4, pp. 222-235
Open Access | Times Cited: 285
Jake G. Natalini, Shivani Singh, Leopoldo N. Segal
Nature Reviews Microbiology (2022) Vol. 21, Iss. 4, pp. 222-235
Open Access | Times Cited: 285
Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
Vyara Matson, Carolina Soto Chervin, Thomas F. Gajewski
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 600-613
Open Access | Times Cited: 280
Vyara Matson, Carolina Soto Chervin, Thomas F. Gajewski
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 600-613
Open Access | Times Cited: 280
Next-generation sequencing: insights to advance clinical investigations of the microbiome
Caroline R. Wensel, Jennifer L. Pluznick, Steven L. Salzberg, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 267
Caroline R. Wensel, Jennifer L. Pluznick, Steven L. Salzberg, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 267
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 263
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 263
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors
Anders B. Dohlman, Jared Klug, Marissa Mesko, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3807-3822.e12
Open Access | Times Cited: 238
Anders B. Dohlman, Jared Klug, Marissa Mesko, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3807-3822.e12
Open Access | Times Cited: 238
Microbiota‐derived extracellular vesicles in interkingdom communication in the gut
Natalia Díaz‐Garrido, Josefa Badı́a, Laura Baldomà
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 13
Open Access | Times Cited: 237
Natalia Díaz‐Garrido, Josefa Badı́a, Laura Baldomà
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 13
Open Access | Times Cited: 237
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 196
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 196
A faecal microbiota signature with high specificity for pancreatic cancer
Ece Kartal, Thomas Schmidt, Esther Molina‐Montes, et al.
Gut (2022) Vol. 71, Iss. 7, pp. 1359-1372
Open Access | Times Cited: 188
Ece Kartal, Thomas Schmidt, Esther Molina‐Montes, et al.
Gut (2022) Vol. 71, Iss. 7, pp. 1359-1372
Open Access | Times Cited: 188
The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants
Anders B. Dohlman, Diana Arguijo Mendoza, Shengli Ding, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 2, pp. 281-298.e5
Open Access | Times Cited: 168
Anders B. Dohlman, Diana Arguijo Mendoza, Shengli Ding, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 2, pp. 281-298.e5
Open Access | Times Cited: 168
Mechanisms of immune activation and regulation: lessons from melanoma
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 168
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 168
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 161
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 161
Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application
Melinda Szilágyi, Ondrej Pös, Éva Márton, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6827-6827
Open Access | Times Cited: 159
Melinda Szilágyi, Ondrej Pös, Éva Márton, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6827-6827
Open Access | Times Cited: 159